Assessing Seven-Year Valve Durability in the PARTNER 3 Trial
-
By
-
Dritan Useini
-
November 1, 2026
By
Dritan Useini
November 1, 2026
In a randomized trial, additional imaging increased preventive treatment but did not significantly reduce subsequent myocardial infarction or cardiac mortality over 3 years.
November 12, 2026
by Debbie Bunch
November 3, 2026
New research identifies metabolic signatures that could help predict which patients with Chagas disease are most likely to develop serious cardiac complications
November 3, 2026